Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3. / Alaux, Sebastien; Kusk, Mie; Sagot, Emanuelle; Bolte, Jean; Jensen, Anders A.; Bräuner-Osborne, Hans; Gefflaut, Thierry; Bunch, Lennart.
In: Journal of Medicinal Chemistry, Vol. 48, No. 25, 2005, p. 7980-92.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3
AU - Alaux, Sebastien
AU - Kusk, Mie
AU - Sagot, Emanuelle
AU - Bolte, Jean
AU - Jensen, Anders A.
AU - Bräuner-Osborne, Hans
AU - Gefflaut, Thierry
AU - Bunch, Lennart
PY - 2005
Y1 - 2005
N2 - A series of nine L-2,4-syn-4-alkylglutamic acid analogues (1a-i) were synthesized in high yield and high enantiomeric excess (>99% ee) from their corresponding 4-substituted ketoglutaric acids (2a-i), using the enzyme aspartate aminotransferase (AAT) from pig heart or E. coli. The synthesized compounds were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay. We found a distinct change in the pharmacological profile when the 4-methyl group (compound 1a, an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-ethyl group, compound 1b, as this analogue is an inhibitor at all three subtypes, EAAT1-3. Furthermore, we conclude that both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn Glu are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.
AB - A series of nine L-2,4-syn-4-alkylglutamic acid analogues (1a-i) were synthesized in high yield and high enantiomeric excess (>99% ee) from their corresponding 4-substituted ketoglutaric acids (2a-i), using the enzyme aspartate aminotransferase (AAT) from pig heart or E. coli. The synthesized compounds were evaluated as potential ligands for the glutamate transporters EAAT1, EAAT2, and EAAT3 (excitatory amino acid transporter, subtypes 1-3) in the FLIPR membrane potential (FMP) assay. We found a distinct change in the pharmacological profile when the 4-methyl group (compound 1a, an EAAT1 substrate and EAAT2,3 inhibitor) was extended to a 4-ethyl group, compound 1b, as this analogue is an inhibitor at all three subtypes, EAAT1-3. Furthermore, we conclude that both large and bulky hydrophobic substituents in the 4-position of L-2,4-syn Glu are allowed by all three glutamate transporter subtypes EAAT1-3 while maintaining inhibitory activity.
KW - Animals
KW - Aspartate Aminotransferases
KW - Cell Line
KW - Excitatory Amino Acid Transporter 2
KW - Excitatory Amino Acid Transporter 3
KW - Glutamates
KW - Humans
KW - Ketoglutaric Acids
KW - Membrane Potentials
KW - Models, Molecular
KW - Myocardium
KW - Stereoisomerism
KW - Structure-Activity Relationship
KW - Swine
U2 - 10.1021/jm050597z
DO - 10.1021/jm050597z
M3 - Journal article
C2 - 16335922
VL - 48
SP - 7980
EP - 7992
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 25
ER -
ID: 38484762